Present all appropriate options to your patient
Current management of BPH is focused on alleviating symptoms. There are many options for managing BPH. These are typically based on the severity of symptoms and patient preference. All of the appropriate options should be discussed with the patient before initiating treatment. Noninvasive pharmacologic treatments may be the preferred option in many cases.1
Explore a variety of useful tools and resources for your practice
Important Safety Information
FLOMAX is indicated to treat the signs and symptoms of benign prostatic hyperplasia (BPH). FLOMAX is not indicated to treat hypertension. As with other alpha-adrenergic blocking agents, there is a potential risk of syncope. Patients beginning treatment with FLOMAX should be cautioned to avoid driving or hazardous tasks for 12 hours after their first dose or increase in dose should syncope occur. The most common side effects are dizziness, abnormal ejaculation, and rhinitis.
Caution should be exercised with concomitant administration of warfarin and FLOMAX. In addition, FLOMAX should be used with caution in combination with cimetidine, particularly at doses higher than 0.4 mg. FLOMAX is contraindicated in patients known to be hypersensitive to tamsulosin HCl or any component of FLOMAX.
Before prescribing FLOMAX, please see the full Prescribing Information.
1. Walsh PC. Benign prostatic hyperplasia. In: Walsh PC, ed. Campbell's Urology. 6th ed. Philadelphia, Pa: WB Saunders Co; 1996:1009-1027.
